Adicet Bio, Inc. Annual Operating Income (Loss) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Adicet Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2023.
  • Adicet Bio, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$33.2M, a 36.6% increase year-over-year.
  • Adicet Bio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$128M, a 15.5% increase year-over-year.
  • Adicet Bio, Inc. annual Operating Income (Loss) for 2023 was -$152M, a 110% decline from 2022.
  • Adicet Bio, Inc. annual Operating Income (Loss) for 2022 was -$72.6M, a 18.1% decline from 2021.
  • Adicet Bio, Inc. annual Operating Income (Loss) for 2021 was -$61.4M, a 56.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$152M -$79.5M -110% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 -$72.6M -$11.1M -18.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 -$61.4M -$22.2M -56.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 -$39.2M -$7.8M -24.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 -$31.4M -$16.4M -110% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 -$15M +$3.92M +20.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-12
2017 -$18.9M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.